What I wish I knew about Multiple Myeloma treatments 25 years later...

Download the FREE ebook "Beating Myeloma: If I Knew Then What I Know Now" and arm yourself with the information about autologous stem cell transplantation, treatment options, and side effects that I wish I had known about when I began treatment.

Wobenzym N- Integrative Multiple Myeloma Therapy

Share Button

Significantly higher overall response rates and longer duration of remissions were observed in the OE-group (Wobenzyme)”

Newly diagnosed multiple myeloma patients are often told that their cancer is “incurable but very treatable (?).” It took me years to figure out what this meant to me. I am a long-term survivor of multiple myeloma. The challenge all myeloma patients face is that conventional oncology considers myeloma to be incurable. Therefore, MMers must either accept the inevitable or look for ways to improve on the long and growing list of conventional (FDA approved) therapies.

Wobenzym N, according to the study linked and excerpted below, is one such integrative cancer therapy.

Wobenzym N – is a broad spectrum blend of enzymes that has shown the ability to fight cancer, reduce blood clots, heal radiation damage and increase the efficacy of chemotherapy. I take the directed dose daily before meals.

“The enteric-coated enzyme preparation (Wobenzym N – ) contained 100 mg of papain, 40 mg of trypsin, and 40 mg of chymotrypsin per tablet…The proportion of patients achieving complete remission, partial remission, or stable disease was significantly higher in the enzyme group than in the control group.”

If you or a loved one have been diagnosed with Multiple Myeloma, let me say this loud and clear:

It is critical that you become an active participant in your care. Learn everything you can.

Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.

Please click on the link below to receive the Free Introductory Guide of my Multiple Myeloma Cancer Coaching Program. There is a coupon code at the end of the video to receive $100 off of the Multiple Myeloma Cancer Coaching Package, and you can scroll down the page to select which package suits your needs.

Your decision-making begins by learning about the full spectrum of evidence-based myeloma therapies, both conventional and non-conventional.  Here are some questions you may have right now:

  • Do Multiple Myeloma specialists know more about MM than regular oncologists? Yes.
  • What side effects should I expect from my induction chemotherapy? Prevention is key.
  • What do I do if I don’t reach complete remission? Don’t panic.
  • What therapies can I use that my oncologist won’t tell me about? Triplets are superior to doublets.
  • Does it matter if I wait to have an autologous stem cell transplant- No. Studies show there is no survival advantage either earlier or later. 

I am both a MM survivor and MM cancer coach. All of these questions are answered in detail in the Multiple Myeloma Cancer Coaching Program. Both the Basic and Premium packages include all 14 guides, plus membership in the Closed Facebook Group, “Beating Myeloma,” a private forum that I moderate for questions and answers among fellow Multiple Myeloma Cancer Coaching members. I hope this information will help you make the best and most informed decisions for your care. It is the information I wish that I had when I was first diagnosed.

Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.

Click here to follow along with the Introduction Guide

Click here to get your FREE First Questions Guide

I wish you all the best on your Multiple Myeloma journey.

Hang in there. If you have a question, scroll down to the bottom to leave a comment, and I will respond ASAP.
David Emerson
  • MM Survivor
  • MM Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:

Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma.

“Results: Significantly higher overall response rates and longer duration of remissions were observed in the OE-group. Primary responders showed a longer mean survival time than non-responders. Additive therapy with OE given for more than 6 months decreased the hazard of death for patients at all stages of disease by approximately 60%. Observation time was not long enough to estimate the median survival for patients at stages I and II; for stage III patients it was 47 months in the control group versus 83 months for the patients treated with OE (P = 0.0014) which means a 3-year gain of survival time. Significant prognostic factors for survival, in the Cox regression analysis, were stage of disease and therapy with OE. The OE-therapy was generally well tolerated (3.6% of patients with mild to moderate gastrointestinal symptoms).

CONCLUSION: OEs represent a promising new additive therapy in multiple myeloma which will be further evaluated in a randomized phase III trial in the USA.”

Wobenzym N – 400 – Tablet (Grocery)

New From: $78.30 USD In Stock
buy now

Leave a Comment:

Add Your Reply